Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Expands By 145.3%

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 67,700 shares, a growth of 145.3% from the March 31st total of 27,600 shares. Based on an average trading volume of 530,200 shares, the days-to-cover ratio is currently 0.1 days.

CV Sciences Stock Performance

CVSI stock opened at $0.04 on Friday. The stock has a market capitalization of $6.15 million, a PE ratio of 1.89 and a beta of 0.62. CV Sciences has a 12-month low of $0.03 and a 12-month high of $0.06. The stock’s 50 day simple moving average is $0.04 and its 200 day simple moving average is $0.04.

CV Sciences (OTCMKTS:CVSI) last released its quarterly earnings data on Thursday, March 28th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $3.80 million during the quarter. CV Sciences had a net margin of 19.38% and a return on equity of 80.98%.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.